Alpha-Lipoic Acid As an Antioxidant Strategy for Managing Neuropathic Pain

Overview

Journal Antioxidants (Basel)

Date 2022 Dec 23

PMID 36552628

Authors

Max Denisson Mauricio Viana

Pedro Santana Sales Lauria

Alyne Almeida de Lima

Luiza Carolina Franca Opretzka

Henrique Rodrigues Marcelino

Cristiane Flora Villarreal

Affiliations

Soon will be listed here.

Abstract

Neuropathic pain (NP) is the most prevalent and debilitating form of chronic pain, caused by injuries or diseases of the somatosensory system. Since current first-line treatments only provide poor symptomatic relief, the search for new therapeutic strategies for managing NP is an active field of investigation. Multiple mechanisms contribute to the genesis and maintenance of NP, including damage caused by oxidative stress. The naturally occurring antioxidant alpha-lipoic acid (ALA) is a promising therapeutic agent for the management of NP. Several pre-clinical in vitro and in vivo studies as well as clinical trials demonstrate the analgesic potential of ALA in the management of NP. The beneficial biological activities of ALA are reflected in the various patents for the development of ALA-based innovative products. This review demonstrates the therapeutic potential of ALA in the management of NP by discussing its analgesic effects by multiple antioxidant mechanisms as well as the use of patented ALA-based products and how technological approaches have been applied to enhance ALA's pharmacological properties.

Citing Articles

Lipoic acid improves wound healing through its immunomodulatory and anti-inflammatory effects in a diabetic mouse model.

Zoheir K, Ali N, Ashour A, Kishta M, Othman S, Rudayni H J Diabetes Metab Disord. 2025; 24(1):56.

PMID: 39868353 PMC: 11759746. DOI: 10.1007/s40200-025-01559-y.

Effects of Short-Term Treatment with α-Lipoic Acid on Neuropathic Pain and Biomarkers of DNA Damage in Patients with Diabetes Mellitus.

Lazutka J, Daniunaite K, Dedonyte V, Popandopula A, Zukaite K, Visockiene Z Pharmaceuticals (Basel). 2024; 17(11).

PMID: 39598447 PMC: 11597811. DOI: 10.3390/ph17111538.

Assessing Gender Differences in Neuropathic Pain Management: Findings from a Real-Life Clinical Cross-Sectional Observational Study.

Marciano G, Siniscalchi A, Di Gennaro G, Rania V, Vocca C, Palleria C J Clin Med. 2024; 13(19).

PMID: 39407742 PMC: 11476643. DOI: 10.3390/jcm13195682.

The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment.

Yan S, Lu J, Chen B, Yuan L, Chen L, Ju L Antioxidants (Basel). 2024; 13(8).

PMID: 39199143 PMC: 11351715. DOI: 10.3390/antiox13080897.

Liquid- and Semisolid-Filled Hard Gelatin Capsules Containing Alpha-Lipoic Acid as a Suitable Dosage Form for Compounding Medicines and Dietary Supplements.

Jovicic-Bata J, Todorovic N, Krstonosic V, Ristic I, Kovacevic Z, Vukovic M Pharmaceutics. 2024; 16(7).

PMID: 39065589 PMC: 11279521. DOI: 10.3390/pharmaceutics16070892.

References

Wang J, Lou Z, Xi H, Li Z, Li L, Li Z . Verification of neuroprotective effects of alpha-lipoic acid on chronic neuropathic pain in a chronic constriction injury rat model. Open Life Sci. 2021; 16(1):222-228. PMC: 7968532. DOI: 10.1515/biol-2021-0026. View

Schupke H, Hempel R, Peter G, Hermann R, Wessel K, Engel J . New metabolic pathways of alpha-lipoic acid. Drug Metab Dispos. 2001; 29(6):855-62. View

Salehi B, Yilmaz Y, Antika G, Tumer T, Mahomoodally M, Lobine D . Insights on the Use of α-Lipoic Acid for Therapeutic Purposes. Biomolecules. 2019; 9(8). PMC: 6723188. DOI: 10.3390/biom9080356. View

Barreto da Silva L, Camargo S, Moraes R, Medeiros C, Jesus A, Evangelista A . Antihypertensive effect of carvacrol is improved after incorporation in β-cyclodextrin as a drug delivery system. Clin Exp Pharmacol Physiol. 2020; 47(11):1798-1807. DOI: 10.1111/1440-1681.13364. View

Kishimoto-Urata M, Urata S, Fujimoto C, Yamasoba T . Role of Oxidative Stress and Antioxidants in Acquired Inner Ear Disorders. Antioxidants (Basel). 2022; 11(8). PMC: 9405327. DOI: 10.3390/antiox11081469. View

Bettiol A, Galora S, Argento F, Fini E, Emmi G, Mattioli I . Erythrocyte oxidative stress and thrombosis. Expert Rev Mol Med. 2022; 24:e31. PMC: 9884766. DOI: 10.1017/erm.2022.25. View

Chen J, Lu J, Xie C, Shen Y, Wang J, Ye X . Caveolin-1 in spinal cord modulates type-2 diabetic neuropathic pain through the Rac1/NOX2/NR2B signaling pathway. Am J Transl Res. 2020; 12(5):1714-1727. PMC: 7269978. View

Eid S, El Massry M, Hichor M, Haddad M, Grenier J, Dia B . Targeting the NADPH Oxidase-4 and Liver X Receptor Pathway Preserves Schwann Cell Integrity in Diabetic Mice. Diabetes. 2019; 69(3):448-464. DOI: 10.2337/db19-0517. View

Xu J, Wu S, Wang J, Wang J, Yan Y, Zhu M . Oxidative stress induced by NOX2 contributes to neuropathic pain via plasma membrane translocation of PKCε in rat dorsal root ganglion neurons. J Neuroinflammation. 2021; 18(1):106. PMC: 8101139. DOI: 10.1186/s12974-021-02155-6. View

10.

Brufani M, Figliola R . (R)-α-lipoic acid oral liquid formulation: pharmacokinetic parameters and therapeutic efficacy. Acta Biomed. 2014; 85(2):108-15. View

11.

Jain S, Lim G . Lipoic acid decreases lipid peroxidation and protein glycosylation and increases (Na(+) + K(+))- and Ca(++)-ATPase activities in high glucose-treated human erythrocytes. Free Radic Biol Med. 2000; 29(11):1122-8. DOI: 10.1016/s0891-5849(00)00410-x. View

12.

Munoz F, Gao R, Tian Y, Henstenburg B, Barrett J, Hu H . Neuronal P2X7 receptor-induced reactive oxygen species production contributes to nociceptive behavior in mice. Sci Rep. 2017; 7(1):3539. PMC: 5471238. DOI: 10.1038/s41598-017-03813-7. View

13.

Zhao R, Jiang S, Zhang L, Yu Z . Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med. 2019; 44(1):3-15. PMC: 6559295. DOI: 10.3892/ijmm.2019.4188. View

14.

Oliveira A, Santos G, Espirito-Santo R, Silva G, Evangelista A, Silva D . Reestablishment of Redox Homeostasis in the Nociceptive Primary Afferent as a Mechanism of Antinociception Promoted by Mesenchymal Stem/Stromal Cells in Oxaliplatin-Induced Chronic Peripheral Neuropathy. Stem Cells Int. 2021; 2021:8815206. PMC: 7808808. DOI: 10.1155/2021/8815206. View

15.

Abdelrahman K, Ibrahim A, Osman A, Aly M, Ali A, Farrag W . Alpha lipoic acid with pulsed radiofrequency in treatment of chronic lumbosacral radicular pain: A prospective, randomized study. Medicine (Baltimore). 2021; 100(24):e26344. PMC: 8213315. DOI: 10.1097/MD.0000000000026344. View

16.

Rochette L, Ghibu S, Muresan A, Vergely C . Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol. 2015; 93(12):1021-7. DOI: 10.1139/cjpp-2014-0353. View

17.

Miao F, Wang R, Cui G, Li X, Wang T, Li X . Engagement of MicroRNA-155 in Exaggerated Oxidative Stress Signal and TRPA1 in the Dorsal Horn of the Spinal Cord and Neuropathic Pain During Chemotherapeutic Oxaliplatin. Neurotox Res. 2019; 36(4):712-723. DOI: 10.1007/s12640-019-00039-5. View

18.

Moura F, de Andrade K, Dos Santos J, Goulart M . Lipoic Acid: its antioxidant and anti-inflammatory role and clinical applications. Curr Top Med Chem. 2015; 15(5):458-83. DOI: 10.2174/1568026615666150114161358. View

19.

Yalcin I, Choucair-Jaafar N, Benbouzid M, Tessier L, Muller A, Hein L . beta(2)-adrenoceptors are critical for antidepressant treatment of neuropathic pain. Ann Neurol. 2009; 65(2):218-25. DOI: 10.1002/ana.21542. View

20.

Hu J, Qin X, Song Z, Yang P, Feng Y, Sun Q . Alpha-lipoic Acid suppresses P2X receptor activities and visceral hypersensitivity to colorectal distention in diabetic rats. Sci Rep. 2017; 7(1):3928. PMC: 5489513. DOI: 10.1038/s41598-017-04283-7. View